To better understand the mechanistic impact of putative VCP inhibitors, we next addressed the hypothesis that SAHA treatment of thyroid cancer cells would induce NIS mRNA expression, and that increased NIS protein might then “benefit” from inhibition of VCP via repressed ERAD to enhance radioiodide uptake. This evidence concerns the gene VCP and thyroid cancer.